Curis (CRIS) – Analyst Comments
-
Truist Securities Starts Curis (CRIS) at Buy; 'The next Pharmacyclics'
-
H.C. Wainwright Reiterates Buy Rating on Curis (CRIS), Comments on Weekend Update
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CRIS Stock Lookup